| Literature DB >> 28894604 |
Damiano Regazzoli1, Pier Pasquale Leone1, Antonio Colombo1,2, Azeem Latib1,2.
Abstract
Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development.Entities:
Keywords: Bioresorbable scaffolds (BRS); coronary artery disease; new technologies
Year: 2017 PMID: 28894604 PMCID: PMC5583081 DOI: 10.21037/jtd.2017.07.104
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895